Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials

Lung Cancer 2026

View at publisher
Authors: Dong Hyun Kim, Miso Kim, Jeonghwan Youk, T Y Kim, Gyeong‐Won Lee, Hyun Sun Kim, Yu Jung Kim, Jin-Soo Kim, Sook Hee Hong, Mi Sun Ahn, Seong Hoon Shin, Dong‐Wan Kim
+2 more Joo-Hang Kim, Bhumsuk Keam
DOI: 10.1016/j.lungcan.2026.108916
Cited by: 0
References: 44

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Metastasis and carcinoma case studies

Publication details

Journal / source
Lung Cancer
Volume
213
Pages
108916–108916
Publication date
11 January 2026
Language
EN